Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Application of PLCL as a biodegradable polymer in biomedical engineering

Zhao Y., Liu H.

Narrative Review on Cartilage Damage, Chronic Wound, published in J Mater Sci Mater Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Mater Sci Mater Med (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41758232
PMCID
PMC12960328
DOI
10.1007/s10856-026-07016-3

Abstract (original English)

Poly (L-lactide-co-ε-caprolactone) (PLCL) is a novel polymer that has attracted considerable attention in the biomedical field due to its exceptional biocompatibility. However, a comprehensive and systematic summary of its diverse applications remains lacking. To address this gap, the present review outlines the physicochemical properties of PLCL and the factors that influence them. Additionally, it consolidates the most commonly employed processing and preparation methods for PLCL in biomedical applications. The review further provides a systematic overview of current applications of PLCL in various biomedical fields, including wound healing, cardiovascular stents, nerve repair, osteochondral tissue engineering, drug delivery, and screening. It also examines modification strategies aimed at enhancing PLCL performance. Ultimately, this review seeks to provide valuable insights for future research and development of PLCL in biomedical contexts.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansPolymersPolyestersBiocompatible MaterialsDrug Delivery SystemsTissue EngineeringMaterials TestingAbsorbable ImplantsBiomedical Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research